Glaucoma Clinical Studies

Clinical studies can help us learn more about eye problems.  Through research and development, physicians can find and try out new ways to treat eye diseases.  Clinical trial participation keeps surgeons on cutting edge of technology.  Our lead glaucoma physician and surgeon is Dr. Scott C. So.  He has been a part of Pacific Eye Associates for over 15+ years.  He’s help many patients manage their glaucoma. In addition, he is a principle investigator for many clinical trials.  Clinical trials keep surgeons on cutting edge of technology.  Dr. So helps prevent, treat and develop new treatments for glaucoma.

Athena Study –  Open-Angle Glaucoma / Ocular Hypertension

Principal Investigator: Dr. Scott C. So, M.D. 

The purpose of this study is to investigate the safety and effectiveness of Bimatoprost SR compared with selective laser trabeculoplasty (SLT) in patient who have glaucoma or ocular hypertension.  This study is sponsored by Allergan. 

Participants will be randomized to one of two study groups:

• Group A—SLT in the primary eye and Bimatoprost SR in the fellow eye
• Group B—Bimatoprost SR in the primary eye and SLT in the fellow eye

Over a period of 14 months, participants will have to be available for:

• 22 scheduled study visit
• 7 phone calls 
• Each visit will last anywhere from two to five hours. 

Key Inclusion Criteria:

• Age ≥ 18 years
• IOP not adequately managed with topical medication for reasons other than medication efficacy—due to intolerance or nonadherence
• IOP ≥ 22 and ≤ 34 mmHg BCVA of 20/50 or better in the study eye

Key Exclusion Criteria:

• History of previous laser trabeculoplasty
• History of traumatic cataract and/or angle recession
• Central corneal thickness of < 480 or > 620 micrometers
• History of peripheral iridotomy/iridectomy in the inferior 180° of the iris
• Any history of trabeculectomy or other types of glaucoma surgery
• History of moderate or worse (≥2+) bulbar conjunctival hyperermia due to prostaglandin, prostamide, or prostaglandin use

For additional information about the trials or to refer a patient, contact our Clinical Research Coordinator: 

Queennie at 415-923-3482 or qkahulugan@pacificeye.com